Coherus Oncology (CHRS) EBITDA Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | 30,424.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,424.00 |
| Dec 31, 2025 | 22,699.00 |
| Sep 30, 2025 | 39,108.00 |
| Jun 30, 2025 | -5,872.00 |
| Mar 31, 2025 | 233,914.00 |
| Dec 31, 2024 | -51,160.00 |
| Sep 30, 2024 | -73,130.00 |
| Jun 30, 2024 | -32,604.00 |
| Mar 31, 2024 | -272,819.00 |
| Dec 31, 2023 | 3,825.00 |
| Sep 30, 2023 | 13,418.00 |
| Jun 30, 2023 | 1,434.00 |
| Mar 31, 2023 | -7,424.00 |
| Dec 31, 2022 | -5,963.00 |
| Sep 30, 2022 | -13,736.00 |
| Jun 30, 2022 | -4,560.00 |
| Mar 31, 2022 | 6,694.00 |
| Dec 31, 2021 | -6,879.00 |
| Sep 30, 2021 | -6,943.00 |
| Jun 30, 2021 | -7,571.00 |